Andreas Engert

Andreas Engert

UNVERIFIED PROFILE

Are you Andreas Engert?   Register this Author

Register author
Andreas Engert

Andreas Engert

Publications by authors named "Andreas Engert"

Are you Andreas Engert?   Register this Author

100Publications

1271Reads

Survivors' perspectives on risks and benefits of Hodgkin lymphoma treatment: results of a survey by the German Hodgkin Study Group.

Leuk Lymphoma 2018 Dec 3:1-10. Epub 2018 Dec 3.

a German Hodgkin Study Group (GHSG), Department of Internal Medicine I , University Hospital of Cologne , Cologne , Germany.

View Article
December 2018

Checkpoint Inhibition in Hodgkin Lymphoma - a Review.

Oncol Res Treat 2017 20;40(11):654-660. Epub 2017 Oct 20.

Department I of Internal Medicine and German Hodgkin Study Group (GHSG), University Hospital of Cologne, Cologne, Germany.

View Article
October 2018

Whole genome sequencing reveals DICER1 as a candidate predisposing gene in familial Hodgkin lymphoma.

Int J Cancer 2018 Oct 26;143(8):2076-2078. Epub 2018 Jul 26.

Division of Molecular Genetic Epidemiology, German Cancer Research Center (DKFZ), Im Neuenheimer Feld 580, Heidelberg, D-69120, Germany.

View Article
October 2018

Outcome of Patients With Early-Stage Infradiaphragmatic Hodgkin Lymphoma: A Comprehensive Analysis From the German Hodgkin Study Group.

J Clin Oncol 2018 Sep 10;36(25):2603-2611. Epub 2018 Jul 10.

Stephanie Sasse, Helen Goergen, Annette Plütschow, Boris Böll, Dennis A. Eichenauer, Michael Fuchs, Karolin Behringer, Christian Baues, Andreas Engert, Peter Borchmann, and Bastian von Tresckow, University Hospital of Cologne, Cologne; Max S. Topp, University Hospital of Würzburg, Würzburg; Julia Meissner, University of Heidelberg, Heidelberg; Andreas Neubauer, Philipps University, Marburg, Germany; Joseé M. Zijlstra, VU University Medical Center, Amsterdam, the Netherlands; Richard Greil, Paracelsus Medical University Salzburg, Salzburg Cancer Research Institute and Arbeitsgemeinschaft Medikamentöse Tumortherapie, Salzburg, Austria; and Jana Markova, Charles University in Prague and Faculty Hospital Kralovske Vinohrady, Prague, Czech Republic.

View Article
September 2018

Hodgkin lymphoma in elderly patients.

Curr Opin Oncol 2018 Sep;30(5):308-316

Department I of Internal Medicine, German Hodgkin Study Group (GHSG).

View Article
September 2018

Symptomatic osteonecrosis as a treatment complication in Hodgkin lymphoma: an analysis of the German Hodgkin Study Group (GHSG).

Leukemia 2018 Aug 21. Epub 2018 Aug 21.

Department I of Internal Medicine and German Hodgkin Study Group (GHSG), University Hospital of Cologne, Cologne, Germany.

View Article
August 2018

Hodgkin Lymphoma in Adults.

Dtsch Arztebl Int 2018 Aug;115(31-32):535-540

Joint first authors; Department I of Internal Medicine, University Hospital Cologne; German Hodgkin Study Group (GHSG), University Hospital Cologne; Evidence-based Oncology, University Hospital Cologne; German Guideline Program in Oncology of the German Cancer Society, Berlin.

View Article
August 2018

Nivolumab for adults with Hodgkin's lymphoma (a rapid review using the software RobotReviewer).

Cochrane Database Syst Rev 2018 07 12;7:CD012556. Epub 2018 Jul 12.

Cochrane Haematological Malignancies Group, Department I of Internal Medicine, University Hospital of Cologne, Kerpener Str. 62, Cologne, Germany.

View Article
July 2018

Leucocyte and eosinophil counts predict progression-free survival in relapsed or refractory classical Hodgkin Lymphoma patients treated with PD1 inhibition.

Br J Haematol 2018 Jun 25;181(6):837-840. Epub 2017 Apr 25.

German Hodgkin Study Group (GHSG), Department I of Internal Medicine, University Hospital Cologne, Cologne, Germany.

View Article
June 2018

Hodgkin Lymphoma-Derived Extracellular Vesicles Change the Secretome of Fibroblasts Toward a CAF Phenotype.

Front Immunol 2018 18;9:1358. Epub 2018 Jun 18.

Clinic for Hematology, Oncology and Immunology, Experimental Tumor Research, Center for Tumor Biology and Immunology, Philipps University, Marburg, Germany.

View Article
June 2018

Nivolumab for Relapsed/Refractory Classic Hodgkin Lymphoma After Failure of Autologous Hematopoietic Cell Transplantation: Extended Follow-Up of the Multicohort Single-Arm Phase II CheckMate 205 Trial.

J Clin Oncol 2018 May 27;36(14):1428-1439. Epub 2018 Mar 27.

Philippe Armand and Margaret A. Shipp, Dana-Farber Cancer Institute, Boston, MA; Andreas Engert, University Hospital of Cologne, Cologne, Germany; Anas Younes, Memorial Sloan Kettering Cancer Center, New York, NY; Michelle Fanale, University of Texas MD Anderson Cancer Center, Houston, TX; Armando Santoro, Humanitas Cancer Center, Humanitas University, Milan; Pier Luigi Zinzani, Institute of Hematology "L. e A. Seràgnoli," University of Bologna, Bologna, Italy; John M. Timmerman, University of California Los Angeles Medical Center, Los Angeles, CA; Graham P. Collins, Oxford Cancer and Haematology Centre, Churchill Hospital, Oxford, United Kingdom; Radhakrishnan Ramchandren, Barbara Ann Karmanos Cancer Institute, Detroit, MI; Jonathon B. Cohen, Winship Cancer Institute, Emory University, Atlanta, GA; Jan Paul De Boer, Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Amsterdam, the Netherlands, on behalf of Lunenburg Lymphoma Phase I/II Consortium; John Kuruvilla, University of Toronto and Princess Margaret Cancer Centre, Toronto, Ontario; Kerry J. Savage, BC Cancer Agency, Vancouver, British Columbia, Canada; Marek Trneny, Charles University, General Hospital in Prague, Prague, Czech Republic; Kazunobu Kato, Anne Sumbul, and Benedetto Farsaci, Bristol-Myers Squibb, Princeton, NJ; and Stephen M. Ansell, Mayo Clinic, Rochester, MN.

View Article
May 2018

Balancing risk and benefit in early-stage classical Hodgkin lymphoma.

Blood 2018 Apr 2;131(15):1666-1678. Epub 2018 Mar 2.

Department I of Internal Medicine and German Hodgkin Study Group (GHSG), University Hospital of Cologne, Cologne, Germany.

View Article
April 2018

Nodular lymphocyte-predominant Hodgkin lymphoma: a unique disease deserving unique management.

Hematology Am Soc Hematol Educ Program 2017 12;2017(1):324-328

First Department of Internal Medicine, University Hospital Cologne, Cologne, Germany; and.

View Article
December 2017

Hodgkin Lymphoma has a seasonal pattern of incidence and mortality that depends on latitude.

Sci Rep 2017 Nov 2;7(1):14903. Epub 2017 Nov 2.

German Hodgkin Study Group (GHSG), Department I of Internal Medicine, University Hospital Cologne, Cologne, Germany.

View Article
November 2017

The evolving role of targeted drugs in the treatment of Hodgkin lymphoma.

Expert Rev Hematol 2017 09 10;10(9):775-782. Epub 2017 Jul 10.

a First Department of Internal Medicine , University Hospital Cologne , Cologne , Germany.

View Article
September 2017

The genetics of Hodgkin lymphoma: an overview and clinical implications.

Curr Opin Oncol 2017 Sep;29(5):307-314

German Hodgkin Study Group (GHSG), Department I of Internal Medicine, University Hospital Cologne, Cologne, Germany.

View Article
September 2017

Optimisation of chemotherapy and radiotherapy for untreated Hodgkin lymphoma patients with respect to second malignant neoplasms, overall and progression-free survival: individual participant data analysis.

Cochrane Database Syst Rev 2017 09 13;9:CD008814. Epub 2017 Sep 13.

Institute of Medical Statistics, Informatics and Epidemiology, University Hospital of Cologne, Kerpener Str. 62, Cologne, Germany, 50937.

View Article
September 2017

R-CHOP in NLPHL: who should receive it?

Blood 2017 07;130(4):387-388

UNIVERSITY HOSPITAL COLOGNE; GERMAN HODGKIN STUDY GROUP.

View Article
July 2017

Late Relapse of Classical Hodgkin Lymphoma: An Analysis of the German Hodgkin Study Group HD7 to HD12 Trials.

J Clin Oncol 2017 May 27;35(13):1444-1450. Epub 2017 Feb 27.

Paul J. Bröckelmann, Helen Goergen, Charlotte Kohnhorst, Bastian von Tresckow, Michael Fuchs, Peter Borchmann, and Andreas Engert, University Hospital of Cologne, Cologne; Julia Meissner, University of Heidelberg, Heidelberg; Andrea Kerkhoff, University Hospital of Münster, Münster; Wolf-Dieter Ludwig, Helios Kinikum Berlin-Buch, Berlin, Germany; Alden Moccia, Swiss Group for Clinical Cancer Research (SAKK), Bern, Switzerland; and Jana Markova, University Hospital Kralovske Vinohrady, Prague, Czech Republic.

View Article
May 2017

Comparison of first-line chemotherapy including escalated BEACOPP versus chemotherapy including ABVD for people with early unfavourable or advanced stage Hodgkin lymphoma.

Cochrane Database Syst Rev 2017 05 25;5:CD007941. Epub 2017 May 25.

Department I of Internal Medicine, University Hospital of Cologne, Kerpener Str. 62, Cologne, Germany, 50924.

View Article
May 2017

Chemotherapy alone versus chemotherapy plus radiotherapy for adults with early stage Hodgkin lymphoma.

Cochrane Database Syst Rev 2017 04 27;4:CD007110. Epub 2017 Apr 27.

Cochrane Haematological Malignancies Group, Department I of Internal Medicine, University Hospital of Cologne, Kerpener Str. 62, Cologne, Germany, 50937.

View Article
April 2017

Evidence of Inbreeding in Hodgkin Lymphoma.

PLoS One 2016 28;11(4):e0154259. Epub 2016 Apr 28.

German Cancer Research Center (DKFZ), Division of Molecular Genetic Epidemiology (C050), Heidelberg, 69120, Germany.

View Article
March 2017

Panobinostat consolidation in patients with Hodgkin lymphoma at risk for relapse after high dose chemotherapy and autologous stem cell transplant: final results after early trial discontinuation.

Leuk Lymphoma 2017 01 17;58(1):222-225. Epub 2016 May 17.

a Department of Internal Medicine I, German Hodgkin Study Group (GHSG) , University Hospital of Cologne , Kerpener Str. 62 , Cologne , Germany.

View Article
January 2017

The emerging role of immune checkpoint inhibition in malignant lymphoma.

Haematologica 2017 01 24;102(1):30-42. Epub 2016 Nov 24.

Department I of Internal Medicine and German Hodgkin Study Group (GHSG), University Hospital of Cologne, Germany

View Article
January 2017

Reply to H.J.A. Adams et al, E.A. Hawkes et al, and C.F. Hess et al.

J Clin Oncol 2017 Jan 28;35(3):375-376. Epub 2016 Oct 28.

Peter Borchmann and Andreas Engert, University Hospital of Cologne and University of Cologne, Cologne, Germany.

View Article
January 2017

Cancer-Related Fatigue in Patients With and Survivors of Hodgkin Lymphoma: The Impact on Treatment Outcome and Social Reintegration.

J Clin Oncol 2016 12 31;34(36):4329-4337. Epub 2016 Oct 31.

Karolin Behringer, Helen Goergen, Horst Müller, Indra Thielen, Corinne Brillant, Stefanie Kreissl, Michael Fuchs, Volker Diehl, Andreas Engert, and Peter Borchmann, University Hospital of Cologne; Jens Ulrich Rueffer, German Fatigue Society, Cologne; Teresa Veronika Halbsguth, University Hospital of Frankfurt, Frankfurt; Julia Meissner, University of Heidelberg, Heidelberg; Hans-Henning Flechtner, Otto von Guericke University, Magdeburg, Germany; Richard Greil, Paracelsus Medical University, Salzburg, Austria; Peter Moosmann, Cantonal Hospital Aarau AG, Aarau and Swiss Group for Clinical Cancer Research, Berne, Switzerland; and Oluwatoyin Shonukan, Boston University School of Public Health, Boston, MA.

View Article
December 2016

Current and future immunotherapeutic approaches in Hodgkin lymphoma.

Leuk Lymphoma 2016 09 31;57(9):2014-24. Epub 2016 May 31.

a Department I of Internal Medicine and German Hodgkin Study Group (GHSG) , University Hospital of Cologne , Cologne , Germany.

View Article
September 2016

Current developments in the treatment of early-stage classical Hodgkin lymphoma.

Curr Opin Oncol 2016 09;28(5):377-83

German Hodgkin Study Group (GHSG), Department I of Internal Medicine, University Hospital Cologne, Cologne, Germany.

View Article
September 2016

Hodgkin lymphoma: Introduction.

Semin Hematol 2016 07 12;53(3):137-8. Epub 2016 May 12.

Department of Haematology, National and Kapodistrian University of Athens School of Medicine, Laikon General Hospital Athens, Greece. Electronic address:

View Article
July 2016

Treatment of early-stage Hodgkin lymphoma.

Semin Hematol 2016 Jul 12;53(3):165-70. Epub 2016 May 12.

Department of Internal Medicine, Rijnstate Hospital, Arnhem, The Netherlands; Department of Hematology, Radboud University Medical Center Nijmegen, Nijmegen, The Netherlands.

View Article
July 2016

Balancing the Risk-Benefit Ratio in the Treatment of Patients With Advanced-Stage Hodgkin Lymphoma.

J Clin Oncol 2016 06 11;34(17):1975-7. Epub 2016 Apr 11.

German Hodgkin Study Group; and University Hospital of Cologne, Cologne, Germany

View Article
June 2016

PET-adapted omission of radiotherapy in early stage Hodgkin lymphoma-a systematic review and meta-analysis.

Crit Rev Oncol Hematol 2016 May 6;101:86-92. Epub 2016 Mar 6.

University Hospital of Cologne, Germany. Electronic address:

View Article
May 2016

ABVD or BEACOPP for Advanced Hodgkin Lymphoma.

Authors:
Andreas Engert

J Clin Oncol 2016 Apr 28;34(11):1167-9. Epub 2015 Dec 28.

University Hospital of Cologne, Cologne, Germany

View Article
April 2016

Granulocyte and granulocyte-macrophage colony stimulating factors for newly diagnosed patients with myelodysplastic syndromes.

Cochrane Database Syst Rev 2016 Feb 16;2:CD009310. Epub 2016 Feb 16.

Cochrane Haematological Malignancies Group, Department I of Internal Medicine, University Hospital of Cologne, Cologne, Germany.

View Article
February 2016

What Is the Role of Rituximab in Nodular Lymphocyte-Predominant Hodgkin Lymphoma?

Acta Haematol 2015 27;134(3):185-6. Epub 2015 May 27.

First Department of Internal Medicine, and German Hodgkin Study Group (GHSG), University Hospital Cologne, Cologne, Germany.

View Article
December 2015

Prophylactic antibiotics or G(M)-CSF for the prevention of infections and improvement of survival in cancer patients receiving myelotoxic chemotherapy.

Cochrane Database Syst Rev 2015 Dec 21(12):CD007107. Epub 2015 Dec 21.

Cochrane Haematological Malignancies Group, Department I of Internal Medicine, University Hospital of Cologne, Kerpener Str. 62, Cologne, Germany, 50937.

View Article
December 2015

Additional plerixafor to granulocyte colony-stimulating factors for haematopoietic stem cell mobilisation for autologous transplantation in people with malignant lymphoma or multiple myeloma.

Cochrane Database Syst Rev 2015 Oct 20(10):CD010615. Epub 2015 Oct 20.

Cochrane Haematological Malignancies Group, Department I of Internal Medicine, University Hospital of Cologne, Cologne, Germany.

View Article
October 2015

The GHSG Approach to Treating Hodgkin's Lymphoma.

Curr Hematol Malig Rep 2015 Sep;10(3):256-65

German Hodgkin Study Group (GHSG) and Department I of Internal Medicine, University Hospital of Cologne, Kerpener Str. 62, 50937, Cologne, Germany.

View Article
September 2015

Long-Term Course of Patients With Stage IA Nodular Lymphocyte-Predominant Hodgkin Lymphoma: A Report From the German Hodgkin Study Group.

J Clin Oncol 2015 Sep 3;33(26):2857-62. Epub 2015 Aug 3.

All authors: University Hospital Cologne, Cologne; and Hans Theodor Eich, University Hospital Münster, Münster, Germany.

View Article
September 2015

Heritability estimates on Hodgkin's lymphoma: a genomic- versus population-based approach.

Eur J Hum Genet 2015 Jun 17;23(6):824-30. Epub 2014 Sep 17.

1] German Cancer Research Center (DKFZ), Division of Molecular Genetic Epidemiology, Heidelberg, Germany [2] Center for Primary Health Care Research, Lund University, Malmö, Sweden.

View Article
June 2015

XVII. Treatment of advanced-stage Hodgkin lymphoma.

Authors:
Andreas Engert

Hematol Oncol 2015 Jun;33 Suppl 1:87-9

University Hospital of Cologne, German Hodgkin Study Group (GHSG), Cologne, Germany.

View Article
June 2015

Hodgkin's lymphoma: who needs consolidation treatment?

Authors:
Andreas Engert

Lancet 2015 May 19;385(9980):1810-2. Epub 2015 Mar 19.

German Hodgkin Study Group, Department of Internal Medicine I, University Hospital of Cologne, Cologne 50937, Germany. Electronic address:

View Article
May 2015

Positron emission tomography-adapted therapy for first-line treatment in individuals with Hodgkin lymphoma.

Cochrane Database Syst Rev 2015 Jan 9;1:CD010533. Epub 2015 Jan 9.

Cochrane Haematological Malignancies Group, Department I of Internal Medicine, University Hospital of Cologne, Cologne, Germany.

View Article
January 2015

Prognostic serum cytokines in classical Hodgkin lymphoma--letter.

Clin Cancer Res 2014 Dec;20(24):6633

University Cancer Center Leipzig (UCCL), University Clinic Leipzig, Leipzig, Germany.

View Article
December 2014

The challenging aspects of managing adolescents and young adults with Hodgkin's lymphoma.

Acta Haematol 2014 10;132(3-4):274-8. Epub 2014 Sep 10.

First Department of Internal Medicine, German Hodgkin Study Group, University of Cologne, Cologne, Germany.

View Article
November 2014

Aerobic physical exercise for adult patients with haematological malignancies.

Cochrane Database Syst Rev 2014 Nov 11(11):CD009075. Epub 2014 Nov 11.

Cochrane Haematological Malignancies Group, Department I of Internal Medicine, University Hospital of Cologne, Cologne, Germany, 50924.

View Article
November 2014

High-dose chemotherapy followed by autologous stem cell transplantation for patients with relapsed or refractory Hodgkin lymphoma: a systematic review with meta-analysis.

Crit Rev Oncol Hematol 2014 Oct 2;92(1):1-10. Epub 2014 May 2.

Cochrane Haematological Malignancies Group, Department I of Internal Medicine, University Hospital of Cologne, Cologne, Germany.

View Article
October 2014

The histone deacetylase inhibitor LBH589 (panobinostat) modulates the crosstalk of lymphocytes with Hodgkin lymphoma cell lines.

PLoS One 2013 21;8(11):e79502. Epub 2013 Nov 21.

Department I of Internal Medicine, Innate Immunity Group, University Clinic Cologne, Cologne, Germany.

View Article
September 2014

Antibodies and antibody-drug conjugates in the treatment of Hodgkin lymphoma.

Eur J Haematol 2014 Jul 9;93(1):1-8. Epub 2014 May 9.

First Department of Internal Medicine, University Hospital Cologne, Cologne, Germany; German Hodgkin Study Group (GHSG), Cologne, Germany.

View Article
July 2014

Assessment of tumor size reduction improves outcome prediction of positron emission tomography/computed tomography after chemotherapy in advanced-stage Hodgkin lymphoma.

J Clin Oncol 2014 Jun 5;32(17):1776-81. Epub 2014 May 5.

Carsten Kobe, Georg Kuhnert, Deniz Kahraman, Heinz Haverkamp, Hans-Theodor Eich, Mareike Franke, Thorsten Persigehl, David Maintz, Michael Fuchs, Peter Borchmann, Volker Diehl, Alexander Drzezga, Andreas Engert, and Markus Dietlein, University Hospital of Cologne, Cologne; Hans-Theodor Eich, University Hospital of Münster, Münster; Susanne Klutmann, University Medical Center Hamburg-Eppendorf, Hamburg; Holger Amthauer, Klinik für Strahlenheilkunde, Charité-Universitätsmedizin Berlin, Campus Virchow-Klinikum, Berlin; Andreas Bockisch, University of Duisburg-Essen, Duisburg and Essen; Regine Kluge, University of Leipzig, Leipzig; and Hans-Heinrich Wolf, Martin Luther University Halle-Wittenberg, Halle, Germany.

View Article
June 2014

Yoga in addition to standard care for patients with haematological malignancies.

Cochrane Database Syst Rev 2014 Jun 12(6):CD010146. Epub 2014 Jun 12.

Cochrane Haematological Malignancies Group, Department I of Internal Medicine, University Hospital of Cologne, Cologne, Germany.

View Article
June 2014

The role of additional radiotherapy for primary central nervous system lymphoma.

Cochrane Database Syst Rev 2014 Jun 16(6):CD009211. Epub 2014 Jun 16.

Cochrane Haematological Malignancies Group, Department I of Internal Medicine, University Hospital of Cologne, Cologne, Germany.

View Article
June 2014

Relapsed hodgkin lymphoma in older patients: a comprehensive analysis from the German hodgkin study group.

J Clin Oncol 2013 Dec 4;31(35):4431-7. Epub 2013 Nov 4.

Boris Böll, Bastian von Tresckow, Dennis A. Eichenauer, Stephanie Sasse, Michael Fuchs, Karolin Behringer, Beate C. Klimm, Andreas Engert, and Peter Borchmann, University Hospital Cologne; Boris Böll, Helen Goergen, Bastian von Tresckow, Dennis A. Eichenauer, Stephanie Sasse, Michael Fuchs, Karolin Behringer, Beate C. Klimm, Volker Diehl, Andreas Engert, and Peter Borchmann, German Hodgkin Study Group, Cologne; Nils Arndt and Ralph Naumann, Stiftungsklinikum Mittelrhein, Koblenz; Julia Meissner, Heidelberg University Hospital, Heidelberg; Stefan W. Krause, Erlangen University Hospital, Erlangen; and Roland Schnell, Pioh Medical Oncology and Hematology, Frechen, Germany.

View Article
December 2013

Effect of initial treatment strategy on survival of patients with advanced-stage Hodgkin's lymphoma: a systematic review and network meta-analysis.

Lancet Oncol 2013 Sep 13;14(10):943-52. Epub 2013 Aug 13.

Cochrane Haematological Malignancies Group, University Hospital of Cologne, Cologne, Germany.

View Article
September 2013